Wedge Implant Narrow Crests: Multi-center Clinical Study

August 25, 2020 updated by: Mr. Claudio Stacchi, DDS, MSc, International Piezosurgery Academy

Wedge Implant for Minimally Invasive Treatment of Narrow Crests: a Prospective Multi-center Clinical Study

This study was designed as a multicentric prospective clinical trial to assess the clinical, biological and patient's perceived success of new wedge-shaped dental implants inserted in narrow ridges.

Study Overview

Status

Completed

Conditions

Detailed Description

Due to the loss of dental elements, the bone crest undergoes a significant remodeling. Bone resorption begins immediately after dental extraction with a 40-60% reduction in horizontal and vertical direction of the alveolar ridge during the first 2 years. The most significant bone loss after tooth extraction occurs within the first 3 months, although modeling and remodeling of the alveoli have a great variability of time: bone structure and organization may not be complete even 24 weeks after dental extraction.

It is now known that crestal remodeling is closely related to the disappearance of the bundle bone, which is more representative of the buccal appearance of the alveolus. Its disappearance, especially in thin periodontal biotopes, can lead to significant recessions of hard and soft tissues.

Moreover, with a variable percentage, in many patients, crestal resorption continues over time due to a combination of factors involved: anatomical, metabolic and mechanical. Among these, the use of removable total or partial dentures can play an important role in accelerating the resurfacing process.

With these premises, it is common to find patients with atrophic crests when processing plans that provide implant support prosthetic rehabilitation.

A crestal bone thickness of at least 6 mm in the buco-lingual sense is considered sufficient to safely place a plant with a diameter of 4 mm. But when the width is lower, a variety of procedures and techniques have been proposed in literature that allow recreate the volumes needed for implant placement.

Horizontal lifting techniques with bone blocks (autologous, alloplastic, xeno-graft), guided bone regeneration, crest expansion technique have demonstrated a good long-term predictability of the inserted devices. However, some negatives related to these techniques need to be considered, such as increased morbidity for the patient, demand for advanced surgical skills for the operator, increased treatment costs, and increased therapy times.

Because of these observations, a new implant design has been proposed for specific use in narrow ridges. Its wedge shape and press-fit insertion make it possible to position it with a minimally invasive preparation of the implant site, performed with ultrasound technique.

Therefore, the use of this implant could allow effective and minimally invasive treatment of narrow edentulous crests up to 4 mm, with significant benefits to the patient in terms of morbidity, treatment costs and time.

Twelve clinical centers will treat patients with insertion of wedge-shaped implants in thin crests with a specific surgical protocol and clinical outcomes will be collected and analyzed.

The chosen medical device will be the Rex Tissue Level implant System. For each implant inserted, the clinical parameters will be recorded up to 5 years after insertion.

In addition, intermediate evaluations will be carried out at 1 year and 3 years after installation.

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • PR
      • Parma, PR, Italy, 43100
        • Piezosurgery Academy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. indications for prosthetic rehabilitation supported by implants in the upper or lower arch, based on accurate diagnosis and treatment planning;
  2. the bone crest must be completely healed (at least six months after the tooth loss);
  3. residual bone ridge width between 3.5 and 5 mm, at least 3 mm in apical direction;
  4. presence of at least 10 mm bone height available for implant placement;
  5. age of the patient> 18 years;
  6. The patient must not carry any removable prosthesis on the treated area;
  7. the patient must be able to follow the protocol of study;
  8. informed written consent

Exclusion Criteria:

  1. acute myocardial infarction over the last 2 months;
  2. uncontrolled coagulation disorders;
  3. unmanaged diabetes (HBA1c> 7.5);
  4. radiotherapy to the head area in the last 24 months;
  5. immunocompromised, HIV positive or chemotherapy patients over the past 5 years;
  6. present or past treatment with intravenous bisphosphonates;
  7. psychological or psychiatric problems;
  8. abuse of alcohol or drugs;
  9. uncontrolled periodontal disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: narrow ridge
edentulous site with crestal bone width comprised between 3,5 and 5 millimeters wedge shape implants insertion
Narrow dental implants inserted in narrow ridges

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
implant survival rate
Time Frame: 1 year after surgery
health of the inserted implants
1 year after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
surgical procedure evaluation
Time Frame: during surgery
handling assessment of the implant system by the surgeons
during surgery
surgical procedure evaluation
Time Frame: 1 hour after surgery
assessment of the invasivity of the surgical procedure from the patient
1 hour after surgery
implant stability 14
Time Frame: 14 days after surgery
resonance frequence analysis of the implant
14 days after surgery
implant stability 1 month
Time Frame: 1 month after surgery
resonance frequence analysis of the implant
1 month after surgery
implant stability 2 months
Time Frame: 2 months after surgery
resonance frequence analysis of the implant
2 months after surgery
implant stability 3 months
Time Frame: 3 months after surgery
resonance frequence analysis of the implant
3 months after surgery
implant stability 4 months
Time Frame: 4 months after surgery
resonance frequence analysis of the implant
4 months after surgery
implant stability 5 months
Time Frame: 5 months after surgery
resonance frequence analysis of the implant
5 months after surgery
implant stability 6 months
Time Frame: 6 months after surgery
resonance frequence analysis of the implant
6 months after surgery
implant stability 1 year
Time Frame: 1 year after surgery
resonance frequence analysis of the implant
1 year after surgery
implant stability 3 years
Time Frame: 3 years after surgery
resonance frequence analysis of the implant
3 years after surgery
implant stability 5 years
Time Frame: 5 years after surgery
resonance frequence analysis of the implant
5 years after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2017

Primary Completion (Actual)

November 15, 2019

Study Completion (Actual)

May 15, 2020

Study Registration Dates

First Submitted

July 21, 2017

First Submitted That Met QC Criteria

September 20, 2017

First Posted (Actual)

September 25, 2017

Study Record Updates

Last Update Posted (Actual)

August 26, 2020

Last Update Submitted That Met QC Criteria

August 25, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alveolar Bone Loss

Clinical Trials on wedge shape implants insertion

3
Subscribe